These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 12712965)
1. Breakthrough treatment for prostate enlargement. Johns Hopkins Med Lett Health After 50; 2003 Apr; 15(2):3, 7. PubMed ID: 12712965 [No Abstract] [Full Text] [Related]
2. Use of alpha-adrenergic inhibitors in treatment of benign prostatic hyperplasia and implications on sexual function. Kaplan SA Urology; 2004 Mar; 63(3):428-34. PubMed ID: 15028431 [No Abstract] [Full Text] [Related]
3. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia]. MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605 [No Abstract] [Full Text] [Related]
4. [The objective of medical treatment: relieve the symptoms or stop the course?]. Desgrandchamps F Ann Urol (Paris); 2006 Mar; 40 Spec No 1():14-6. PubMed ID: 16649585 [No Abstract] [Full Text] [Related]
5. A new take on prostate drugs. Johns Hopkins Med Lett Health After 50; 1998 Apr; 10(2):1-2. PubMed ID: 9552801 [No Abstract] [Full Text] [Related]
6. Pharmacological options in the treatment of benign prostatic hyperplasia. Kenny B; Ballard S; Blagg J; Fox D J Med Chem; 1997 Apr; 40(9):1293-315. PubMed ID: 9135028 [No Abstract] [Full Text] [Related]
7. [A trial of the use of finasteride and terazosin in patients with benign prostatic hyperplasia]. Pushkar' DIu; Kosko DV; Loran OB; Kan IaD; Sapozhnikov IM; Tevlin KP Urol Nefrol (Mosk); 1995; (4):32-5. PubMed ID: 7571199 [TBL] [Abstract][Full Text] [Related]
8. Finasteride in benign prostatic hyperplasia. Verhamme KM; Bosch RJ; Sturkenboom MC N Engl J Med; 2004 Mar; 350(13):1359-61; author reply 1359-61. PubMed ID: 15049034 [No Abstract] [Full Text] [Related]
9. Medical management of benign prostatic hyperplasia--are two drugs better than one? Vaughan ED N Engl J Med; 2003 Dec; 349(25):2449-51. PubMed ID: 14681512 [No Abstract] [Full Text] [Related]
10. Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile. Crawford ED BJU Int; 2005 Jun; 95 Suppl 4():1-5. PubMed ID: 15871729 [No Abstract] [Full Text] [Related]
11. 5alpha-reductase inhibition for men with enlarged prostate. Issa MM; Kraft KH J Am Acad Nurse Pract; 2007 Aug; 19(8):398-407. PubMed ID: 17655569 [TBL] [Abstract][Full Text] [Related]
12. Clinical management of lower urinary tract symptoms with combined medical therapy. Roehrborn CG BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605 [No Abstract] [Full Text] [Related]
14. Medical management of lower urinary tract symptoms in men: current treatment and future approaches. Patel AK; Chapple CR Nat Clin Pract Urol; 2008 Apr; 5(4):211-9. PubMed ID: 18301417 [TBL] [Abstract][Full Text] [Related]
15. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate. Naslund MJ; Miner M Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044 [TBL] [Abstract][Full Text] [Related]
16. What is the best medical treatment for benign prostate hyperplasia? Evans MF; Frank J Can Fam Physician; 1997 Jun; 43():1073-4. PubMed ID: 9189295 [No Abstract] [Full Text] [Related]